| Literature DB >> 1387464 |
E F McCance-Katz1, K L Marek, L H Price.
Abstract
A 55-year-old man presented with a 5-year history of Parkinson's disease and a 6-month history of major depression. The patient's depressive symptoms responded to treatment with fluvoxamine, a selective and potent serotonin reuptake inhibitor. Tryptophan depletion testing, which acutely lowers central serotonin levels, caused a brief exacerbation of the depressive illness, which resolved upon tryptophan repletion. Serotonergic dysfunction may be an etiologic factor in depression that occurs in Parkinson's disease.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1387464 DOI: 10.1212/wnl.42.9.1813
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910